New drug trial offers hope for people with uncontrollable chronic hives
NCT ID NCT07415551
Summary
This study is testing whether a new drug called lesigercept can help adults with chronic spontaneous urticaria (long-lasting hives with no clear cause) when standard antihistamine medicines don't work well enough. About 150 participants will receive either lesigercept or a placebo (inactive substance) via injection every 4 weeks for 12 weeks, followed by a 4-week observation period. The main goal is to see if lesigercept safely reduces hive activity and improves quality of life compared to the placebo.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC SPONTANEOUS URTICARIA (CSU) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
ALL-MED Specjalistyczna Opieka Medyczna
Wroclaw, Lower Silesian Voivodeship, 53-201, Poland
-
Ajou University Hospital
Gyeonggi-do, Suwon, 16499, South Korea
-
Alergo-Med Ośrodek Badań Klinicznych Sp. z o.o.
Tarnów, Lesser Poland Voivodeship, 33-100, Poland
-
Alergologia Plus Sp. z o. o.
Poznan, Greater Poland Voivodeship, 60-693, Poland
-
Asan Medical Center
Seoul, Songpa-gu, 05505, South Korea
-
Bio Zdrowie sp. z o.o.
Bialystok, Podlaskie Voivodeship, 15-698, Poland
-
Centrum Medyczne ALL-MED
Krakow, Lesser Poland Voivodeship, 30-033, Poland
-
Centrum Nowoczesnych Terapii "Dobry Lekarz" Sp. z o.o.
Krakow, Lesser Poland Voivodeship, 31-011, Poland
-
Chung-Ang University Hospital
Seoul, Dongjak-gu, 06973, South Korea
-
Clinic Infertility Treatment Angelius Provita (Centrum Medyczne Angelius Provita)
Katowice, Silesian Voivodeship, 40-611, Poland
-
DERMACEUM sp. z o.o., DERMACEUM Centrum Medyczne
Wroclaw, Lower Silesian Voivodeship, 53-613, Poland
-
Dermatology Hospital of Southern Medical University (Guangdong Province Dermatology Hospital)
Guangzhou, Guangdong, 510000, China
-
Diagnostic & Consultative Centre Ascendent EOOD
Sofia, Sofia, 1202, Bulgaria
-
Hallym University Kangnam Sacred Heart Hospital
Seoul, Seoul, 07441, South Korea
-
Inha University Hospital
Incheon, Incheon, 22332, South Korea
-
Keimyung University Dongsan Hospital
Daegu, Dalseo-gu, 42601, South Korea
-
Korea University Ansan Hospital
Gyeonggi-do, Danwon-gu, 15355, South Korea
-
Kyung Hee University Hospital at Gangdong
Seoul, Seoul, 05278, South Korea
-
Medical Center Hera EOOD
Sofia, Sofia, 1510, Bulgaria
-
NZOZ GynCentrum Oddział Libero
Katowice, Silesian Voivodeship, 40-600, Poland
-
Prof. Dorota Krasowska LUXDERM Specjalistyczny Gabinet Dermatologiczny
Lublin, Lublin Voivodeship, 20-573, Poland
-
Prywatny Gabinet Internistyczno-Alergologiczny Prof. dr hab. Zenon Siergiejko
Bialystok, Podlaskie Voivodeship, 15-010, Poland
-
Pusan National University Yangsan Hospital
Yangsan, Gyeongsangnam-do, 50612, South Korea
-
Seoul National University Bundang Hospital
Gyeonggi-do, Bundang-gu, 13620, South Korea
-
Seoul St. Mary's Hospital, The Catholic University of Korea
Seoul, Seocho-gu, 06591, South Korea
-
Severance Hospital, Yonsei University Health System
Seoul, Seodaemun-gu, 03722, South Korea
-
The University of Hong Kong-Shenzhen Hospital
Shenzhen, Guangdong, 518053, China
-
UMHAT "Aleksandrovska"
Sofia, Sofia, 1431, Bulgaria
-
UMHATEM "N. I. Pirogov"
Sofia, Sofia, 1606, Bulgaria
-
Uniwersytecki Szpital Kliniczny w Opolu
Opole, Opolskie Voivodeship, 45-401, Poland
Conditions
Explore the condition pages connected to this study.